The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
The global Pressurized Metered-dose Inhaler market size is expected to reach US$ 7418.6 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Pressurized Metered-dose Inhaler in various end use industries.
The expanding demands from the Hospitals and Ambulatory Surgery Centres, are propelling Pressurized Metered-dose Inhaler market. Single-dose Inhalers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Multi-dose Inhalers segment is estimated at % CAGR for the next seven-year period.
The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.
Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.
North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.
Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pressurized Metered-dose Inhaler, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pressurized Metered-dose Inhaler market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pressurized Metered-dose Inhaler market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pressurized Metered-dose Inhaler sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pressurized Metered-dose Inhaler covered in this report include Glenmark Pharmaceuticals(India), Novartis International AG(Switzerland), Propeller Health(USA), AstraZeneca Plc(Sweden), Philips Respironics(Netherlands), Teva Pharmaceutical Industries(Israel), Opko Health(USA), Merck(USA) and BioCare Group(Malaysia), etc.
The global Pressurized Metered-dose Inhaler market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Glenmark Pharmaceuticals(India)
- Novartis International AG(Switzerland)
- Propeller Health(USA)
- AstraZeneca Plc(Sweden)
- Philips Respironics(Netherlands)
- Teva Pharmaceutical Industries(Israel)
- Opko Health(USA)
- Merck(USA)
- BioCare Group(Malaysia)
Global Pressurized Metered-dose Inhaler market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pressurized Metered-dose Inhaler market, Segment by Type:
- Single-dose Inhalers
- Multi-dose Inhalers
Global Pressurized Metered-dose Inhaler market, by Application
- Hospitals
- Ambulatory Surgery Centres
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pressurized Metered-dose Inhaler manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pressurized Metered-dose Inhaler in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Pressurized Metered-dose Inhaler Market Overview
1.1 Pressurized Metered-dose Inhaler Product Overview
1.2 Pressurized Metered-dose Inhaler Market Segment by Type
1.2.1 Single-dose Inhalers
1.2.2 Multi-dose Inhalers
1.3 Global Pressurized Metered-dose Inhaler Market Size by Type
1.3.1 Global Pressurized Metered-dose Inhaler Market Size Overview by Type (2018-2029)
1.3.2 Global Pressurized Metered-dose Inhaler Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pressurized Metered-dose Inhaler Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pressurized Metered-dose Inhaler Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pressurized Metered-dose Inhaler Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pressurized Metered-dose Inhaler Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pressurized Metered-dose Inhaler Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pressurized Metered-dose Inhaler Sales Breakdown by Type (2018-2023)
2 Global Pressurized Metered-dose Inhaler Market Competition by Company
2.1 Global Top Players by Pressurized Metered-dose Inhaler Sales (2018-2023)
2.2 Global Top Players by Pressurized Metered-dose Inhaler Revenue (2018-2023)
2.3 Global Top Players by Pressurized Metered-dose Inhaler Price (2018-2023)
2.4 Global Top Manufacturers Pressurized Metered-dose Inhaler Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pressurized Metered-dose Inhaler Market Competitive Situation and Trends
2.5.1 Pressurized Metered-dose Inhaler Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pressurized Metered-dose Inhaler Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pressurized Metered-dose Inhaler as of 2022)
2.7 Date of Key Manufacturers Enter into Pressurized Metered-dose Inhaler Market
2.8 Key Manufacturers Pressurized Metered-dose Inhaler Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pressurized Metered-dose Inhaler Status and Outlook by Region
3.1 Global Pressurized Metered-dose Inhaler Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pressurized Metered-dose Inhaler Historic Market Size by Region
3.2.1 Global Pressurized Metered-dose Inhaler Sales in Volume by Region (2018-2023)
3.2.2 Global Pressurized Metered-dose Inhaler Sales in Value by Region (2018-2023)
3.2.3 Global Pressurized Metered-dose Inhaler Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pressurized Metered-dose Inhaler Forecasted Market Size by Region
3.3.1 Global Pressurized Metered-dose Inhaler Sales in Volume by Region (2024-2029)
3.3.2 Global Pressurized Metered-dose Inhaler Sales in Value by Region (2024-2029)
3.3.3 Global Pressurized Metered-dose Inhaler Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pressurized Metered-dose Inhaler by Application
4.1 Pressurized Metered-dose Inhaler Market Segment by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgery Centres
4.2 Global Pressurized Metered-dose Inhaler Market Size by Application
4.2.1 Global Pressurized Metered-dose Inhaler Market Size Overview by Application (2018-2029)
4.2.2 Global Pressurized Metered-dose Inhaler Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pressurized Metered-dose Inhaler Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pressurized Metered-dose Inhaler Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pressurized Metered-dose Inhaler Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pressurized Metered-dose Inhaler Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pressurized Metered-dose Inhaler Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pressurized Metered-dose Inhaler Sales Breakdown by Application (2018-2023)
5 North America Pressurized Metered-dose Inhaler by Country
5.1 North America Pressurized Metered-dose Inhaler Historic Market Size by Country
5.1.1 North America Pressurized Metered-dose Inhaler Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pressurized Metered-dose Inhaler Sales in Volume by Country (2018-2023)
5.1.3 North America Pressurized Metered-dose Inhaler Sales in Value by Country (2018-2023)
5.2 North America Pressurized Metered-dose Inhaler Forecasted Market Size by Country
5.2.1 North America Pressurized Metered-dose Inhaler Sales in Volume by Country (2024-2029)
5.2.2 North America Pressurized Metered-dose Inhaler Sales in Value by Country (2024-2029)
6 Europe Pressurized Metered-dose Inhaler by Country
6.1 Europe Pressurized Metered-dose Inhaler Historic Market Size by Country
6.1.1 Europe Pressurized Metered-dose Inhaler Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pressurized Metered-dose Inhaler Sales in Volume by Country (2018-2023)
6.1.3 Europe Pressurized Metered-dose Inhaler Sales in Value by Country (2018-2023)
6.2 Europe Pressurized Metered-dose Inhaler Forecasted Market Size by Country
6.2.1 Europe Pressurized Metered-dose Inhaler Sales in Volume by Country (2024-2029)
6.2.2 Europe Pressurized Metered-dose Inhaler Sales in Value by Country (2024-2029)
7 Asia-Pacific Pressurized Metered-dose Inhaler by Region
7.1 Asia-Pacific Pressurized Metered-dose Inhaler Historic Market Size by Region
7.1.1 Asia-Pacific Pressurized Metered-dose Inhaler Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pressurized Metered-dose Inhaler Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pressurized Metered-dose Inhaler Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pressurized Metered-dose Inhaler Forecasted Market Size by Region
7.2.1 Asia-Pacific Pressurized Metered-dose Inhaler Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pressurized Metered-dose Inhaler Sales in Value by Region (2024-2029)
8 Latin America Pressurized Metered-dose Inhaler by Country
8.1 Latin America Pressurized Metered-dose Inhaler Historic Market Size by Country
8.1.1 Latin America Pressurized Metered-dose Inhaler Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pressurized Metered-dose Inhaler Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pressurized Metered-dose Inhaler Sales in Value by Country (2018-2023)
8.2 Latin America Pressurized Metered-dose Inhaler Forecasted Market Size by Country
8.2.1 Latin America Pressurized Metered-dose Inhaler Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pressurized Metered-dose Inhaler Sales in Value by Country (2024-2029)
9 Middle East and Africa Pressurized Metered-dose Inhaler by Country
9.1 Middle East and Africa Pressurized Metered-dose Inhaler Historic Market Size by Country
9.1.1 Middle East and Africa Pressurized Metered-dose Inhaler Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pressurized Metered-dose Inhaler Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pressurized Metered-dose Inhaler Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pressurized Metered-dose Inhaler Forecasted Market Size by Country
9.2.1 Middle East and Africa Pressurized Metered-dose Inhaler Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pressurized Metered-dose Inhaler Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Glenmark Pharmaceuticals(India)
10.1.1 Glenmark Pharmaceuticals(India) Company Information
10.1.2 Glenmark Pharmaceuticals(India) Introduction and Business Overview
10.1.3 Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Products Offered
10.1.5 Glenmark Pharmaceuticals(India) Recent Development
10.2 Novartis International AG(Switzerland)
10.2.1 Novartis International AG(Switzerland) Company Information
10.2.2 Novartis International AG(Switzerland) Introduction and Business Overview
10.2.3 Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Products Offered
10.2.5 Novartis International AG(Switzerland) Recent Development
10.3 Propeller Health(USA)
10.3.1 Propeller Health(USA) Company Information
10.3.2 Propeller Health(USA) Introduction and Business Overview
10.3.3 Propeller Health(USA) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Propeller Health(USA) Pressurized Metered-dose Inhaler Products Offered
10.3.5 Propeller Health(USA) Recent Development
10.4 AstraZeneca Plc(Sweden)
10.4.1 AstraZeneca Plc(Sweden) Company Information
10.4.2 AstraZeneca Plc(Sweden) Introduction and Business Overview
10.4.3 AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2018-2023)
10.4.4 AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Products Offered
10.4.5 AstraZeneca Plc(Sweden) Recent Development
10.5 Philips Respironics(Netherlands)
10.5.1 Philips Respironics(Netherlands) Company Information
10.5.2 Philips Respironics(Netherlands) Introduction and Business Overview
10.5.3 Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Products Offered
10.5.5 Philips Respironics(Netherlands) Recent Development
10.6 Teva Pharmaceutical Industries(Israel)
10.6.1 Teva Pharmaceutical Industries(Israel) Company Information
10.6.2 Teva Pharmaceutical Industries(Israel) Introduction and Business Overview
10.6.3 Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Products Offered
10.6.5 Teva Pharmaceutical Industries(Israel) Recent Development
10.7 Opko Health(USA)
10.7.1 Opko Health(USA) Company Information
10.7.2 Opko Health(USA) Introduction and Business Overview
10.7.3 Opko Health(USA) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Opko Health(USA) Pressurized Metered-dose Inhaler Products Offered
10.7.5 Opko Health(USA) Recent Development
10.8 Merck(USA)
10.8.1 Merck(USA) Company Information
10.8.2 Merck(USA) Introduction and Business Overview
10.8.3 Merck(USA) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Merck(USA) Pressurized Metered-dose Inhaler Products Offered
10.8.5 Merck(USA) Recent Development
10.9 BioCare Group(Malaysia)
10.9.1 BioCare Group(Malaysia) Company Information
10.9.2 BioCare Group(Malaysia) Introduction and Business Overview
10.9.3 BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Sales, Revenue and Gross Margin (2018-2023)
10.9.4 BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Products Offered
10.9.5 BioCare Group(Malaysia) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pressurized Metered-dose Inhaler Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pressurized Metered-dose Inhaler Industrial Chain Analysis
11.4 Pressurized Metered-dose Inhaler Market Dynamics
11.4.1 Pressurized Metered-dose Inhaler Industry Trends
11.4.2 Pressurized Metered-dose Inhaler Market Drivers
11.4.3 Pressurized Metered-dose Inhaler Market Challenges
11.4.4 Pressurized Metered-dose Inhaler Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pressurized Metered-dose Inhaler Distributors
12.3 Pressurized Metered-dose Inhaler Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
